Holen Sie sich die Stockscreener-App
3.70
3.92%
0.13
Schlusskurs vom Vortag:
$3.57
Offen:
$3.66
24-Stunden-Volumen:
245.73K
Relative Volume:
0.21
Marktkapitalisierung:
$325.69M
Einnahmen:
$73.48M
Nettoeinkommen (Verlust:
$-108.30M
KGV:
-1.6444
EPS:
-2.25
Netto-Cashflow:
$-67.17M
1W Leistung:
-10.39%
1M Leistung:
-32.67%
6M Leistung:
-34.80%
1J Leistung:
+134.81%
1-Tages-Spanne:
$3.62
$3.78
1-Wochen-Bereich:
$3.38
$4.0366
52-Wochen-Spanne:
$1.135
$7.20
Personalis Inc Stock (PSNL) Company Profile
Firmenname
Personalis Inc
Sektor
Branche
Telefon
650-752-1300
Adresse
6600 DUMBARTON CIRCLE, FREMONT, CA
Vergleichen Sie PSNL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
3.70 | 325.69M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
516.75 | 195.34B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
208.66 | 149.60B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
119.20 | 33.84B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
413.04 | 33.52B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
183.79 | 32.24B | 15.41B | 1.37B | 2.11B | 7.50 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-02-06 | Hochstufung | Needham | Hold → Buy |
| 2022-01-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Herabstufung | Needham | Buy → Hold |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-20 | Bestätigt | Needham | Buy |
| 2021-05-06 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-12 | Bestätigt | Needham | Buy |
| 2020-11-06 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Eingeleitet | Citigroup | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-08-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-07-15 | Eingeleitet | Cowen | Outperform |
| 2019-07-15 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-07-15 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Personalis Inc Aktie (PSNL) Neueste Nachrichten
Hold Rating for Personalis: Balancing Strong Enterprise Sales and Future Uncertainties - TipRanks
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga
Personalis Stock Price, Quotes and Forecasts | NASDAQ:PSNL - Benzinga
Personalis stock target cut to $7 by BTIG, maintains Buy rating - Investing.com Canada
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection - Yahoo Finance
Personalis’ (PSNL) “Buy” Rating Reiterated at HC Wainwright - Defense World
Needham & Company LLC Cuts Personalis (NASDAQ:PSNL) Price Target to $7.00 - Defense World
Personalis, Inc. (NASDAQ:PSNL) Just Reported Earnings, And Analysts Cut Their Target Price - Simply Wall St
Personalis (NASDAQ:PSNL) Price Target Lowered to $7.00 at Needham & Company LLC - MarketBeat
Personalis Full Year 2024 Earnings: Beats Expectations - Yahoo Finance UK
Personalis (NASDAQ:PSNL) Announces Quarterly Earnings Results - MarketBeat
Personalis stock target cut to $7.00 at Needham, retains buy rating By Investing.com - Investing.com South Africa
Personalis (NASDAQ:PSNL) Announces Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
Personalis files to sell 14.04M shares of common stock for holders - MSN
Personalis stock target cut to $7.00 at Needham, retains buy rating - Investing.com Canada
Personalis, Inc. (NASDAQ:PSNL) Q4 2024 Earnings Call Transcript - Insider Monkey
A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts - Benzinga
Personalis Inc (PSNL) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
ARK Investment Management LLC Sells 310,088 Shares of Personalis, Inc. (NASDAQ:PSNL) - MarketBeat
Personalis Inc (PSNL) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Personalis: Q4 Earnings Snapshot - Thehour.com
Personalis’ Earnings Call: Growth Amid Challenges - TipRanks
Personalis Reports Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Personalis Reports 2024 Growth and Strategic Partnerships - TipRanks
Personalis (PSNL) Reports Q4 Loss, Tops Revenue Estimates - MSN
Earnings call transcript: Personalis Q4 2024 beats EPS forecast, stock dips - Investing.com India
Personalis: Q4 Earnings Snapshot -February 27, 2025 at 04:23 pm EST - Marketscreener.com
Personalis price target lowered to $8 from $11 at H.C. Wainwright - MSN
Personalis Inc to Host Earnings Call - ACCESS Newswire
Personalis Inc (PSNL) Q4 2024 Earnings Report Preview: What To L - GuruFocus.com
Personalis Inc (PSNL) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Personalis Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates - MSN
Personalis Inc (NASDAQ: PSNL) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
Personalis (PSNL) to Release Earnings on Thursday - MarketBeat
Personalis (PSNL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Personalis Inc (PSNL) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
Personalis (PSNL) Projected to Post Earnings on Wednesday - Defense World
Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference - Business Wire
PSNLPersonalis Latest Stock News & Market Updates - StockTitan
297,889 Shares in Personalis, Inc. (NASDAQ:PSNL) Bought by abrdn plc - MarketBeat
Exciting Technology At Personalis, But Profitability Eludes Them (NASDAQ:PSNL) - Seeking Alpha
SG Americas Securities LLC Buys New Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Sumitomo Mitsui Trust Group Inc. Sells 59,295 Shares of Personalis, Inc. (NASDAQ:PSNL) - MarketBeat
Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Cancer Genomics Pioneer Personalis Unveils Q4 Earnings DateKey Details Inside - StockTitan
Understanding the Risks of Investing in Personalis Inc (PSNL) - Knox Daily
Wall Street analysts’ outlook for Personalis Inc (PSNL) - SETE News
Should You Expect A Quick Recovery From Personalis Inc (NASDAQ: PSNL) After -35.08% Decline From High? - Marketing Sentinel
BlackRock, Inc.'s Strategic Acquisition of Personalis Inc. Shares - GuruFocus.com
Personalis Inc (PSNL) is a good investment, but the stock may be overvalued - US Post News
Finanzdaten der Personalis Inc-Aktie (PSNL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Personalis Inc-Aktie (PSNL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 28 '25 |
Sale |
5.79 |
519 |
3,005 |
123,367 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Dec 16 '24 |
Sale |
3.82 |
4,834 |
18,466 |
123,886 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
| Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
| Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Nov 18 '24 |
Sale |
3.79 |
1,693 |
6,416 |
67,388 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Nov 18 '24 |
Sale |
3.79 |
921 |
3,491 |
128,720 |
| Hall Christopher M | PRESIDENT AND CEO |
Nov 01 '24 |
Sale |
5.38 |
26,443 |
142,263 |
178,098 |
| Tempus AI, Inc. | 10% Owner |
Aug 16 '24 |
Buy |
5.07 |
3,500,000 |
17,745,000 |
12,718,800 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jul 30 '24 |
Sale |
2.97 |
524 |
1,556 |
127,227 |
1.53%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):